Conference
Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Results of Two 52-Week, Phase III, Randomized, Placebo-Controlled Trials (INPULSIS™)
Authors
Richeldi L; Du Bois R; Raghu G; Azuma A; Brown KK; Costabel U; Cottin V; Flaherty K; Inoue Y; Kim DS
Volume
189
Pagination
pp. a6603-a6603
Publication Date
January 1, 2014
DOI
10.1164/ajrccm-conference.2014.189.1_meetingabstracts.a6603
Conference proceedings
American Journal of Respiratory and Critical Care Medicine
Issue
Supplement_1
ISSN
1073-449X
